<DOC>
	<DOCNO>NCT01510860</DOCNO>
	<brief_summary>The purpose study compare efficacy Ursofalk 500 mg tablet versus Ursofalk 500 mg capsule treatment Primary Biliary Cirrhosis ( PBC ) .</brief_summary>
	<brief_title>Ursofalk Tablets ( 500 mg ) Versus Ursofalk Capsules ( 250 mg ) Treatment Primary Biliary Cirrhosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Liver Cirrhosis , Biliary</mesh_term>
	<mesh_term>Ursodeoxycholic Acid</mesh_term>
	<criteria>Negative pregnancy Signed informed consent Histologically proven noncirrhotic liver disease histologically proven cirrhosis PBC stage II+IV Positive HIV serology</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>